Veracyte VCYT Current ratio

Current ratio at other companies

Myriad GeneticsMYGN

2.4×+0.5×

Biodesix, Inc.BDSX

2.8×+0.7×

Castle BiosciencesCSTL

6.7×-2.6×

Personalis, Inc.PSNL

6.6×-0.3×

Guardant HealthGH

4.7×+0.6×

Natera, Inc.NTRA

3×-0.7×

FAQ

What is Veracyte's current ratio?

Veracyte (VCYT) reported current ratio of 9.3× in Q1 2026.

How has Veracyte's current ratio changed year-over-year?

Veracyte's current ratio increased by 82.5% year-over-year, from 5.1× to 9.3×.

What is the long-term trend for Veracyte's current ratio?

Over 5 years (2020 to 2025), Veracyte's current ratio has grown at a -18.3% compound annual growth rate (CAGR), from 22.4× to 8.1×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.